Latest Insider Transactions at Intuitive Surgical Inc (ISRG)
This section provides a real-time view of insider transactions for Intuitive Surgical Inc (ISRG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTUITIVE SURGICAL INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTUITIVE SURGICAL INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 27
2023
|
Amal M Johnson |
BUY
Exercise of conversion of derivative security
|
Direct |
482
+3.95%
|
-
|
|
Apr 24
2023
|
David J. Rosa President |
SELL
Open market or private sale
|
Direct |
40,764
-20.75%
|
$12,188,436
$299.2 P/Share
|
|
Apr 24
2023
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
54,000
+21.56%
|
$2,268,000
$42.64 P/Share
|
|
Apr 21
2023
|
David J. Rosa President |
SELL
Open market or private sale
|
Direct |
40,800
-22.26%
|
$12,117,600
$297.92 P/Share
|
|
Apr 21
2023
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
54,000
+22.76%
|
$2,268,000
$42.64 P/Share
|
|
Apr 21
2023
|
Mark J Rubash Director |
SELL
Open market or private sale
|
Direct |
9,818
-3.15%
|
$2,915,946
$297.93 P/Share
|
|
Apr 21
2023
|
Mark J Rubash Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,818
+3.04%
|
$1,286,158
$131.94 P/Share
|
|
Apr 21
2023
|
Fredrik Widman VP Corporate Controller |
SELL
Open market or private sale
|
Direct |
630
-22.0%
|
$187,110
$297.87 P/Share
|
|
Apr 21
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
8,623
-11.74%
|
$2,561,031
$297.94 P/Share
|
|
Apr 21
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
6,260
+9.55%
|
$1,314,600
$210.91 P/Share
|
|
Apr 21
2023
|
Craig H Barratt Director |
SELL
Open market or private sale
|
Direct |
6,000
-100.0%
|
$1,782,000
$297.92 P/Share
|
|
Apr 21
2023
|
Craig H Barratt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+50.0%
|
$246,000
$41.26 P/Share
|
|
Apr 21
2023
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,623
-61.03%
|
$2,877,277
$299.48 P/Share
|
|
Apr 21
2023
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+38.31%
|
$1,360,000
$170.44 P/Share
|
|
Mar 01
2023
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,253
-39.12%
|
$285,684
$228.47 P/Share
|
|
Feb 28
2023
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,501
-20.28%
|
$343,729
$229.39 P/Share
|
|
Feb 28
2023
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,259
+29.6%
|
-
|
|
Feb 28
2023
|
Fredrik Widman VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
456
-7.83%
|
$104,424
$229.39 P/Share
|
|
Feb 28
2023
|
Fredrik Widman VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,317
+18.17%
|
-
|
|
Feb 28
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
1,705
-8.68%
|
$390,445
$229.39 P/Share
|
|
Feb 28
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
3,679
+15.68%
|
-
|
|
Feb 28
2023
|
Marshall Mohr Executive VP Global Business S |
SELL
Payment of exercise price or tax liability
|
Direct |
1,617
-3.27%
|
$370,293
$229.39 P/Share
|
|
Feb 28
2023
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
3,259
+6.13%
|
-
|
|
Feb 28
2023
|
Gary S Guthart CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,159
-5.03%
|
$723,411
$229.39 P/Share
|
|
Feb 28
2023
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,371
+9.17%
|
-
|
|
Feb 28
2023
|
Jamie Samath |
SELL
Payment of exercise price or tax liability
|
Direct |
696
-5.63%
|
$159,384
$229.39 P/Share
|
|
Feb 28
2023
|
Jamie Samath |
BUY
Exercise of conversion of derivative security
|
Direct |
2,009
+13.84%
|
-
|
|
Feb 28
2023
|
David J. Rosa President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,865
-0.72%
|
$427,085
$229.39 P/Share
|
|
Feb 28
2023
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,760
+1.43%
|
-
|
|
Feb 28
2023
|
Henry L Charlton SVP & Chief Commercial and Mkt |
SELL
Payment of exercise price or tax liability
|
Direct |
744
-1.81%
|
$170,376
$229.39 P/Share
|
|
Feb 28
2023
|
Henry L Charlton SVP & Chief Commercial and Mkt |
BUY
Exercise of conversion of derivative security
|
Direct |
2,201
+5.05%
|
-
|
|
Feb 26
2023
|
Fredrik Widman VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
212
-9.58%
|
$48,972
$231.05 P/Share
|
|
Feb 26
2023
|
Fredrik Widman VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
609
+21.57%
|
-
|
|
Feb 26
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
501
-6.3%
|
$115,731
$231.05 P/Share
|
|
Feb 26
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
1,590
+16.66%
|
-
|
|
Feb 26
2023
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
592
-29.06%
|
$136,752
$231.05 P/Share
|
|
Feb 26
2023
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,710
+45.64%
|
-
|
|
Feb 26
2023
|
Gary S Guthart CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,449
-5.04%
|
$334,719
$231.05 P/Share
|
|
Feb 26
2023
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,030
+9.53%
|
-
|
|
Feb 26
2023
|
David J. Rosa President |
SELL
Payment of exercise price or tax liability
|
Direct |
848
-0.66%
|
$195,888
$231.05 P/Share
|
|
Feb 26
2023
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,710
+1.32%
|
-
|
|
Feb 26
2023
|
Henry L Charlton SVP & Chief Commercial and Mkt |
SELL
Payment of exercise price or tax liability
|
Direct |
387
-1.99%
|
$89,397
$231.05 P/Share
|
|
Feb 26
2023
|
Henry L Charlton SVP & Chief Commercial and Mkt |
BUY
Exercise of conversion of derivative security
|
Direct |
1,284
+6.19%
|
-
|
|
Feb 26
2023
|
Jamie Samath |
SELL
Payment of exercise price or tax liability
|
Direct |
445
-8.46%
|
$102,795
$231.05 P/Share
|
|
Feb 26
2023
|
Jamie Samath |
BUY
Exercise of conversion of derivative security
|
Direct |
1,284
+19.62%
|
-
|
|
Feb 26
2023
|
Marshall Mohr Executive VP Global Business S |
SELL
Payment of exercise price or tax liability
|
Direct |
848
-3.63%
|
$195,888
$231.05 P/Share
|
|
Feb 26
2023
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
1,710
+6.83%
|
-
|
|
Feb 16
2023
|
Fredrik Widman VP Corporate Controller |
SELL
Open market or private sale
|
Direct |
116
-6.74%
|
$27,840
$240.77 P/Share
|
|
Feb 16
2023
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,124
-77.46%
|
$269,760
$240.77 P/Share
|
|
Feb 16
2023
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
1,971
-23.64%
|
$473,040
$240.77 P/Share
|